PEPGEN INC

Explore PepGen Inc., the biotech pioneer in oligonucleotide therapeutics targeting neuromuscular and neurological diseases—investors, patients, and science leaders watching its breakthrough potential.

Explore PepGen Inc.’s biotech ambitions and volatile Nasdaq stock, noting its negative P/E, 52‑week highs and lows, and future therapeutic potential.

PepGen Inc.’s stock has experienced significant volatility, with a 52-week high of $19.29 and a low of $0.88, raising questions about the company’s valuation and financial stability.